Anti-ANTR2/ ANTXR2/ CMG-2 monoclonal antibody
Anti-ANTR2/ ANTXR2/ CMG-2 antibody for FACS & in-vivo assay
Go to ANTXR2/ANTXR2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-MP0069-Ab-1/ GM-Tg-hg-MP0069-Ab-2 | Anti-Human ANTXR2 monoclonal antibody | Human |
GM-Tg-rg-MP0069-Ab-1/ GM-Tg-rg-MP0069-Ab-2 | Anti-Rat ANTXR2 monoclonal antibody | Rat |
GM-Tg-mg-MP0069-Ab-1/ GM-Tg-mg-MP0069-Ab-2 | Anti-Mouse ANTXR2 monoclonal antibody | Mouse |
GM-Tg-cynog-MP0069-Ab-1/ GM-Tg-cynog-MP0069-Ab-2 | Anti-Cynomolgus/ Rhesus macaque ANTXR2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-MP0069-Ab-1/ GM-Tg-felg-MP0069-Ab-2 | Anti-Feline ANTXR2 monoclonal antibody | Feline |
GM-Tg-cang-MP0069-Ab-1/ GM-Tg-cang-MP0069-Ab-2 | Anti-Canine ANTXR2 monoclonal antibody | Canine |
GM-Tg-bovg-MP0069-Ab-1/ GM-Tg-bovg-MP0069-Ab-2 | Anti-Bovine ANTXR2 monoclonal antibody | Bovine |
GM-Tg-equg-MP0069-Ab-1/ GM-Tg-equg-MP0069-Ab-2 | Anti-Equine ANTXR2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-MP0069-Ab-1/ GM-Tg-hg-MP0069-Ab-2; GM-Tg-rg-MP0069-Ab-1/ GM-Tg-rg-MP0069-Ab-2; GM-Tg-mg-MP0069-Ab-1/ GM-Tg-mg-MP0069-Ab-2; GM-Tg-cynog-MP0069-Ab-1/ GM-Tg-cynog-MP0069-Ab-2; GM-Tg-felg-MP0069-Ab-1/ GM-Tg-felg-MP0069-Ab-2; GM-Tg-cang-MP0069-Ab-1/ GM-Tg-cang-MP0069-Ab-2; GM-Tg-bovg-MP0069-Ab-1/ GM-Tg-bovg-MP0069-Ab-2; GM-Tg-equg-MP0069-Ab-1/ GM-Tg-equg-MP0069-Ab-2 |
Products Name | Anti-ANTXR2 monoclonal antibody |
Format | mab |
Target Name | ANTXR2 |
Protein Sub-location | Transmembrane Protein |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-ANTXR2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation | Lyophilized from sterile PBS, PH 7.4 |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | Products Developing | Multi-species ANTR2/ ANTXR2/ CMG-2 VLP (virus-like particle) (Products Developing) |
ORF Viral Vector | pGMLV000377 | human ANTXR2 Lentivirus plasmid |
ORF Viral Vector | vGMAP000277 | Human 0 Adenovirus particle |
ORF Viral Vector | vGMLV000377 | human ANTXR2 Lentivirus particle |
ORF Viral Vector | pGMAP000277 | Human 0 Adenovirus plasmid |
ORF Viral Vector | pGMLPm005335 | mouse Antxr2 Lentivirus plasmid |
ORF Viral Vector | vGMLPm005335 | mouse Antxr2 Lentivirus particle |
Target information
Target ID | GM-MP0069 |
Target Name | ANTXR2 |
Gene ID | 118429,71914,305633,696513,487821,101094174,510080,100051770 |
Gene Symbol and Synonyms | 2310046B19Rik,ANTXR2,cI-35,CMG-2,CMG2,HFS,ISH,JHF |
Uniprot Accession | P58335 |
Uniprot Entry Name | ANTR2_HUMAN |
Protein Sub-location | Transmembrane Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000163297 |
Target Classification | N/A |
The target: ANTXR2, gene name: ANTXR2, also named as CMG-2, CMG2, HFS, ISH, JHF. This gene encodes a receptor for anthrax toxin. The protein binds to collagen IV and laminin, suggesting that it may be involved in extracellular matrix adhesion. Mutations in this gene cause juvenile hyaline fibromatosis and infantile systemic hyalinosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.